Smartphone Microscopic Method Detects Cryptosporidium and Giardia
|
By LabMedica International staff writers Posted on 30 Sep 2020 |

Image: Cryptosporidium oocysts and the larger Giardia cysts stained by Crypto/Giardia IFA kit (Photo courtesy of Cellabs).
Food and water-borne illness arising from the consumption of contaminated food and water are serious health hazards globally. Cryptosporidium and Giardia are the major food and water‒borne parasites. The infection occurs mainly by (oo)cyst phase of the parasites.
Several highly sensitive and specific methods have been described to detect Giardia cyst and Cryptosporidium oocyst in food, water, and fecal samples. Commonly used approaches are polymerase chain reaction, flow cytometry, and optical microscopic examination. However, these techniques need a good laboratory facility, well trained user and are expensive.
Scientists at the Kathmandu Institute of Applied Sciences (Kathmandu, Nepal) developed a smartphone based microscopic assay method to screen (oo)cysts of Cryptosporidium and Giardia contamination of vegetable and water samples. The method consisting of a ball lens of 1 mm diameter, white LED as illumination source and Lugols's iodine staining provided magnification and contrast capable of distinguishing (oo)cysts of Cryptosporidium and Giardia. The analytical performance of the method was tested by spike recovery studies.
Ten microliters of concentrated sample were stained with 10 μL of diluted Lugol's iodine (1:2 in water) and subsequently loaded into hemocytometer. The sample was incubated for six minutes. The (oo)cysts were screened and enumerated in four quadrants of the hemocytometer under smartphone microscope. The cysts on the same hemocytometer were simultaneously counted by Trinocular brightfield microscope (Amscope, Irvine, CA, USA). Triplicate measurement was made for each concentrated suspension. The spiked samples were also examined with a fluorescent microscope (Labomed Inc, Los Angeles, CA, USA).
The team tested the smartphone microscope system for detecting (oo)cysts on seven types of vegetable (n = 196) and river water (n = 18) samples. They reported that 42% vegetable and 39% water samples were found to be contaminated with Cryptosporidium oocyst. Similarly, 31% vegetable and 33% water samples were contaminated with Giardia cyst. The recovery of Giardia ranged from 10.2 ± 4.0% in cabbage to 37.6 ± 2.4% in water and recovery of Cryptosporidium ranged from 26.8 ± 10.3% in cabbage to 49.2 ± 10.9% in tomato using smartphone microscope measurement.
The authors concluded that the smartphone based microscopic assay can be a low-cost alternative for screening of (oo)cyst of Cryptosporidium and Giardia in resource limited settings. The approximate cost of the microscope (excluding the cost of smartphone) is ~ USD 15. This method also has the potential to be used in clinical settings. The study was published on September 8, 2020 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Kathmandu Institute of Applied Sciences
Amscope
Labomed Inc
Several highly sensitive and specific methods have been described to detect Giardia cyst and Cryptosporidium oocyst in food, water, and fecal samples. Commonly used approaches are polymerase chain reaction, flow cytometry, and optical microscopic examination. However, these techniques need a good laboratory facility, well trained user and are expensive.
Scientists at the Kathmandu Institute of Applied Sciences (Kathmandu, Nepal) developed a smartphone based microscopic assay method to screen (oo)cysts of Cryptosporidium and Giardia contamination of vegetable and water samples. The method consisting of a ball lens of 1 mm diameter, white LED as illumination source and Lugols's iodine staining provided magnification and contrast capable of distinguishing (oo)cysts of Cryptosporidium and Giardia. The analytical performance of the method was tested by spike recovery studies.
Ten microliters of concentrated sample were stained with 10 μL of diluted Lugol's iodine (1:2 in water) and subsequently loaded into hemocytometer. The sample was incubated for six minutes. The (oo)cysts were screened and enumerated in four quadrants of the hemocytometer under smartphone microscope. The cysts on the same hemocytometer were simultaneously counted by Trinocular brightfield microscope (Amscope, Irvine, CA, USA). Triplicate measurement was made for each concentrated suspension. The spiked samples were also examined with a fluorescent microscope (Labomed Inc, Los Angeles, CA, USA).
The team tested the smartphone microscope system for detecting (oo)cysts on seven types of vegetable (n = 196) and river water (n = 18) samples. They reported that 42% vegetable and 39% water samples were found to be contaminated with Cryptosporidium oocyst. Similarly, 31% vegetable and 33% water samples were contaminated with Giardia cyst. The recovery of Giardia ranged from 10.2 ± 4.0% in cabbage to 37.6 ± 2.4% in water and recovery of Cryptosporidium ranged from 26.8 ± 10.3% in cabbage to 49.2 ± 10.9% in tomato using smartphone microscope measurement.
The authors concluded that the smartphone based microscopic assay can be a low-cost alternative for screening of (oo)cyst of Cryptosporidium and Giardia in resource limited settings. The approximate cost of the microscope (excluding the cost of smartphone) is ~ USD 15. This method also has the potential to be used in clinical settings. The study was published on September 8, 2020 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Kathmandu Institute of Applied Sciences
Amscope
Labomed Inc
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







